Loading…
← CockpitCompetitor Analysis › 300138.SZ Chenguang Biotech Group Co., Ltd. Class AOpen in the cockpit ↗

Chenguang Biotech Group Co., Ltd. Class A300138.SZCompetitor analysis, valuation and peers

China · CNY·Consumer Staples›Food: Specialty/Candy
Momentum leader 95
Mkt cap
$946M
US dollars, full cap
Free float
80%
of shares outstanding
$/day
$15.6M
20-day average traded
Fwd P/E
16.1×
forward earnings
ROIC−WACC
+3.7 pp
WACC 5.0%
Hurdle
-12 pp
Req g minus delivered
Next earnings
144 days
30 Mar 2027
Close · CNYCN¥13.06
1D-0.5%
1W+2.9%
1M+14.6%
3M+12.1%
6M+13.3%
YTD+5.2%
1Y-10.7%
ATR %3.4%
52w lowhigh17.3% off high

What Chenguang Biotech does

Employees: 2,079

Chenguang Biotech at a glance

Size Chenguang Biotech (300138.SZ) is a China Consumer Staples company (Food: Specialty/Candy) with a market value of $946M, the 2407th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥13.06 on 6 Nov 2026.

Performance Over six months the shares gained 13.3%, against -5.2% for the median peer and -16.4% for the China market (cap-weighted) — 2nd highest of 20 in its peer set.

Growth Revenue fell 3.9% over the last twelve months (peer median +5.3%); the operating margin is 6.2% (peer median 6.5%).

Valuation It trades at 16.1× forward earnings against a peer median of 17.4× (6th cheapest of 14).

Price implies For today's price to make sense, revenue must grow about -1% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is -12 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 3.7 points above its cost of capital (5.0% WACC).

Next results Next results expected around 30 Mar 2027 (exchange calendar; dates can move).

Relative performance

8010011 May 202611 Aug 20266 Nov 2026300138.SZ 116Peer median 96
Six months, rebased to 100: Chenguang Biotech against the median of its 20 peers (local-currency closes).

Chenguang Biotech financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥6.54BCN¥6.55BCN¥6.98BCN¥6.87BCN¥6.29B
Revenue growth—-6%+2%+9%—
Gross profitCN¥897MCN¥811MCN¥488MCN¥754MCN¥827M
EBITDAn/aCN¥595MCN¥287MCN¥633MCN¥593M
Net incomeCN¥335MCN¥369MCN¥94.0MCN¥480MCN¥434M
Free cash flowCN¥131MCN¥147M-CN¥334M-CN¥700MCN¥579M
Capital expenditureCN¥154MCN¥135MCN¥150MCN¥189MCN¥176M
Total debtCN¥4.43BCN¥5.12BCN¥4.91BCN¥4.22BCN¥2.84B

Quarterly statements and history in the cockpit →

Chenguang Biotech competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-25%0%+25%+50%-20%0%+20%002956F03002650605339007310WESTSENEA603609001800495860086614756001270030004914280360300138.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Chenguang Biotech is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%20×40×002956F03007310SENEA603609281549586008661475ORKLAINDIA0030004914280360300138.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Chenguang Biotech is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%+40%0%25%50%002956F03002650007310SENEA6036090018001475ORKLAINDIA002481280360300138.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Chenguang Biotech is the large dot.

Chenguang Biotech competitors and peer comparison

How Chenguang Biotech compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Chenguang Biotech against its 20 peers (data as of 6 Nov 2026)
Measure300138.SZPeer medianRank in peer set
1-month return+14.6%+0.8%2nd highest of 21
6-month return+13.3%-5.2%2nd highest of 20
Distance from 52-week high-17.3%-25.3%4th highest of 21
Revenue growth (TTM)-3.9%+5.3%3rd lowest of 21
Operating margin6.2%6.5%11th highest of 21
Forward P/E16.1×17.4×6th cheapest of 14
Growth the price implies (Req g, 7 yrs)-1.0%-4.8%7th most demanding of 14
Growth delivered (Del g)+10.9%+7.2%4th highest of 14
Hurdle (Req g minus delivered)-11.9 pp-13.6 pp6th most demanding of 14
ROIC minus cost of capital+3.7 pp+0.5 pp8th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Chenguang Biotech 300138.SZChina$946M+13%-4%6%16.1×-1.0%+10.9%
Guilin Seamild Foods 002956.SZChina$947M-14%+21%11%23.3×9.0%+17.0%
Food Empire F03.SISingapore$952M-22%+14%16%12.7×-9.9%+14.9%
Jiajia Food 002650.SZChina$983M-25%-3%-11%n/a1.2%-10.0%
Namchow Food Group (Shanghai) 605339.SSChina$1.01B-2%-5%-1%n/an/an/a
Otoki 007310.KSSouth Korea$879M-13%+4%5%9.4×-6.5%+7.2%
Westrock Coffee WESTUnited States$878M+9%+39%0%n/an/an/a
Seneca Foods SENEAUnited States$1.03B+9%+12%9%10.9×-15.1%+2.5%
Wellhope Foods 603609.SSChina$870M-8%+7%0%53.8×54.2%+8.5%
ARIAKE JAPAN 2815.TJapan$1.04B-5%+3%17%17.4×-7.4%+6.1%
ORION 001800.KSSouth Korea$1.06B-4%+15%15%n/a-16.5%+8.3%
T. Hasegawa 4958.TJapan$847M+12%+7%12%17.1×-4.8%+7.9%
Star Lake Bioscience 600866.SSChina$1.07B-26%-3%0%37.2×n/an/a
Nissin Foods 1475.HKHong Kong$834M-14%+1%13%19.0×-13.0%+2.6%
JinJian Cereals Industry 600127.SSChina$1.08B+64%+1%-1%n/an/an/a
Orkla India ORKLAINDIA.NSIndia$826M-12%+6%14%22.8×13.4%+5.3%
Jiangxi Qiyunshan Food 2797.HKHong Kong$1.10Bn/a-7%17%n/an/an/a
Jinzai Food 003000.SZChina$810M-17%+14%8%17.7×n/an/a
Takasago International 4914.TJapan$809M+9%+1%3%13.3×n/an/a
Yan Tai Shuang Ta Food 002481.SZChina$803M-4%+5%2%n/a17.7%+1.2%
Lotte Wellfood 280360.KSSouth Korea$796M+2%+7%4%8.8×0.4%+15.2%

Questions

Which companies are Chenguang Biotech's closest peers?
The cockpit's peer set: Guilin Seamild Foods (002956.SZ), Food Empire (F03.SI), Jiajia Food (002650.SZ), Namchow Food Group (Shanghai) (605339.SS), Otoki (007310.KS), Westrock Coffee (WEST), Seneca Foods (SENEA), Wellhope Foods (603609.SS).
Is Chenguang Biotech expensive compared with its peers?
On forward p/e it trades at 16.1× against a peer median of 17.4×, 6th cheapest of 14 in its peer set. For today's price to make sense, revenue must grow about -1% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is -12 pp: the price already allows for a slowdown.
How has Chenguang Biotech stock performed?
Over six months to 6 Nov 2026 the shares returned +13.3% against -5.2% for the median peer; over one year -10.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.